ANDREA WEINTHALER: Open Payments
NPI 1609160142 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 11 payments from 5 companies in 2025. Trend: 2023 $64 · 2024 $46 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $187 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Grifols USA, LLC | 2 | $61 |
| ABBVIE INC. | 2 | $43 |
| Lilly USA, LLC | 1 | $23 |
Products named: DUPIXENT, NUCALA, Prolastin-C Liquid, ZEPBOUND, EPKINLY, EMBLAVEO.
Industry payments across GA — which companies pay providers there.
